QVT Associates GP LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), bought 642,509 shares at $6.26 ($4.0M) on 2013-07-05, disclosed to the SEC on 2013-07-09.
Open-market purchase of $4.0M ACHN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.21 | 72,300 | $449K | 11.1% |
| 2 | $6.26 | 125,000 | $783K | 19.4% |
| 3 | $6.30 | 445,209 | $2.8M | 69.5% |
| Total | $6.28 avg | 642,509 | $4.0M | 100% |
| Filing → |
| UROV | BUY | 2019-06-03 | $278K | — | Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-23 | $326K | — | Filing → |